{
  "hash": "3fbff71fc145382b55223c5e39695e6e",
  "result": {
    "engine": "jupyter",
    "markdown": "---\ntitle: \"Clinical Trial Watch\"\n---\n\n## Monitoring Status\n\nThis page monitors specific clinical trials and highlights any updates in their status or key fields.\n\n[Download Status Summary (CSV)](data/status_summary.csv)\n\n| Trial ID | Sponsor | Update | Status | Conditions | Phases | Start | End | Enroll | Last Updated |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| [NCT05101070](https://clinicaltrials.gov/study/NCT05101070) | Shionogi | 游릭 No Change | RECRUITING | Solid Tumors | PHASE1, PHASE2 | 2022-05-30 | 2027-04-16 | 274 | 2025-05-22 |\n| [NCT07362186](https://clinicaltrials.gov/study/NCT07362186) | LaNova Medicines Limited | 游릭 No Change | NOT_YET_RECRUITING | Locally Advanced or Metastatic GC and GCJ Adenocarcinoma | PHASE3 | 2026-04-03 | 2028-09-28 | 400 | 2026-01-15 |\n| [NCT06387628](https://clinicaltrials.gov/study/NCT06387628) | Fudan University | 游릭 No Change | RECRUITING | TNBC - Triple-Negative Breast Cancer | PHASE2 | 2024-07-10 | 2027-04-01 | 74 | 2024-08-01 |\n| [NCT07213882](https://clinicaltrials.gov/study/NCT07213882) | Assistance Publique - H칪pitaux de Paris | 游릭 No Change | NOT_YET_RECRUITING | Cutaneous T Cell Lymphoma (CTCL), Mycosis Fungoides, Sezary Syndrome | EARLY_PHASE1 | 2026-01-01 | 2028-08-01 | 30 | 2025-10-02 |\n| [NCT05537740](https://clinicaltrials.gov/study/NCT05537740) | Bayer | 游릭 No Change | ACTIVE_NOT_RECRUITING | Advanced Solid Tumors | PHASE1 | 2022-10-11 | 2027-05-04 | 129 | 2026-01-21 |\n| [NCT05007782](https://clinicaltrials.gov/study/NCT05007782) | Gilead Sciences | 游릭 No Change | RECRUITING | Advanced Solid Tumor | PHASE1 | 2021-08-18 | 2028-12 | 416 | 2025-12-26 |\n| [NCT07205718](https://clinicaltrials.gov/study/NCT07205718) | Takeda | 游릭 No Change | RECRUITING | Advanced or Metastatic Solid Tumors | PHASE1, PHASE2 | 2025-11-19 | 2029-12-21 | 223 | 2025-11-28 |\n| [NCT05635643](https://clinicaltrials.gov/study/NCT05635643) | Coherus Oncology, Inc. | 游릭 No Change | RECRUITING | Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma | PHASE1 | 2022-12-15 | 2026-02 | 87 | 2025-07-30 |\n| [NCT05935098](https://clinicaltrials.gov/study/NCT05935098) | BeiGene | 游릭 No Change | ACTIVE_NOT_RECRUITING | Advanced Solid Tumor, Metastatic Solid Tumor, Solid Tumor | PHASE1 | 2023-08-21 | 2027-03-31 | 263 | 2025-06-23 |\n| [NCT06657144](https://clinicaltrials.gov/study/NCT06657144) | Coherus Oncology, Inc. | 游릭 No Change | RECRUITING | Metastatic Solid Tumor, Advanced Solid Tumor | PHASE1 | 2025-04-01 | 2027-05 | 154 | 2026-01-12 |\n| [NCT06620822](https://clinicaltrials.gov/study/NCT06620822) | Shanghai Pulmonary Hospital, Shanghai, China | 游릭 No Change | NOT_YET_RECRUITING | Non Small Cell Lung Cancer | PHASE2 | 2024-09-30 | 2027-09-30 | 296 | 2024-09-28 |\n| [NCT07226856](https://clinicaltrials.gov/study/NCT07226856) | Mayo Clinic | 游릭 No Change | RECRUITING | Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 | PHASE2 | 2025-12-12 | 2028-12-01 | 43 | 2025-12-19 |\n\n\n[View Full Change History](history.qmd)\n\n",
    "supporting": [
      "index_files"
    ],
    "filters": [],
    "includes": {}
  }
}